Effects of initial and long-term lipid-lowering therapy on vascular wall characteristics

FL Ubels*, JHJ Muntinga, JJ van Doormaal, AJ Smit

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Scopus)

Abstract

Several studies have demonstrated the beneficial effects of 3 hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors on vascular properties, but little is known about treatment intensification. We compared patients in whom statins were started (INITIAL, n = 30) for hypercholesterolaemia (>6.5 mmol l(-1)) with a matched patient group of long-time statin users, with similar baseline characteristics for lipids, intima-media thickness (IMT), and pulse wave velocity, in whom treatment with statins was intensified (LONG-TERM, n = 54). At baseline and after 1 year, lipid profile, IMT of the carotid and femoral arteries, aortic distensibility using pulse-wave velocity and various properties of the peripheral vascular bed using a recently developed bio-impedance method were measured. After 1 year the relative changes in lipid profile were significantly better in the INITIAL compared with the LONG-TERM-group, The relative changes in IMT of the mean internal carotid and common femoral arteries significantly differed between the INITIAL and LONG-TERM-group (-8 and +11%, -11 and +22%, respectively). After 1 year, in both groups, most other vascular wall characteristics were unaltered compared with baseline. In conclusion, the beneficial structural alterations of the vascular wall were greater after starting than after intensifying already existing lipid-lowering treatment. This suggests that other effects of HMG-CoA reductase inhibitors than lipid-lowering alone must be involved in vascular changes. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)155-161
Number of pages7
JournalAtherosclerosis
Volume154
Issue number1
Publication statusPublished - Jan-2001

Keywords

  • hypercholesterolaemia
  • lipid-lowering drugs
  • 3 hydroxy-3-methylglutaryl-coenzyme reductase inhibitor
  • clinical trial
  • intima-media thickness
  • vascular wall
  • INTIMA-MEDIA THICKNESS
  • B-MODE ULTRASOUND
  • CLINICAL IMPLICATIONS
  • ENDOTHELIAL FUNCTION
  • DRUG-TREATMENT
  • ARTERIAL-WALL
  • CHOLESTEROL
  • PRAVASTATIN
  • FLUVASTATIN
  • HYPERCHOLESTEROLEMIA

Fingerprint

Dive into the research topics of 'Effects of initial and long-term lipid-lowering therapy on vascular wall characteristics'. Together they form a unique fingerprint.

Cite this